GI Dynamics - Defining Noninvasive Metabolic Control

The Ideal Solution

Current treatment options for type 2 diabetes and obesity are inadequate. There is a significant unmet medical need for new treatment options that can effectively address the growing epidemics of type 2 diabetes and obesity.

The ideal solution would address the limitations associated with drug therapy and surgery and would have the following characteristics:

  • Eliminate or reduce the risks and side effects associated with pharmaceutical regimens and surgical options
  • Reduce patient anxiety and fear of surgery
  • Reduce recuperative time
  • Address the issue of patient non-compliance
  • Immediate reduction in glycemic levels to resolve type 2 diabetes
  • Ability to achieve significant weight loss 
  • Ability to be easily removed or be reversible once the desired effect has been attained and lifestyle changes implemented

With the EndoBarrier™ Gastrointestinal Liner, GI Dynamics is defining a new class of treatment options between pharmaceutical regimens and surgery called nonsurgical therapeutics. This platform of technologies affects key metabolic pathways resulting in gastric bypass-like resolution of type 2 diabetes and significant weight loss.